Correlation Between Akros Monthly and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both Akros Monthly and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akros Monthly and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akros Monthly Payout and Goldman Sachs ActiveBeta, you can compare the effects of market volatilities on Akros Monthly and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akros Monthly with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akros Monthly and Goldman Sachs.
Diversification Opportunities for Akros Monthly and Goldman Sachs
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akros and Goldman is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Akros Monthly Payout and Goldman Sachs ActiveBeta in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs ActiveBeta and Akros Monthly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akros Monthly Payout are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs ActiveBeta has no effect on the direction of Akros Monthly i.e., Akros Monthly and Goldman Sachs go up and down completely randomly.
Pair Corralation between Akros Monthly and Goldman Sachs
Given the investment horizon of 90 days Akros Monthly Payout is expected to generate 0.71 times more return on investment than Goldman Sachs. However, Akros Monthly Payout is 1.4 times less risky than Goldman Sachs. It trades about 0.24 of its potential returns per unit of risk. Goldman Sachs ActiveBeta is currently generating about -0.09 per unit of risk. If you would invest 2,523 in Akros Monthly Payout on September 1, 2024 and sell it today you would earn a total of 79.00 from holding Akros Monthly Payout or generate 3.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Akros Monthly Payout vs. Goldman Sachs ActiveBeta
Performance |
| Timeline |
| Akros Monthly Payout |
| Goldman Sachs ActiveBeta |
Akros Monthly and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akros Monthly and Goldman Sachs
The main advantage of trading using opposite Akros Monthly and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akros Monthly position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| Akros Monthly vs. iShares Core Growth | Akros Monthly vs. ClearShares OCIO ETF | Akros Monthly vs. Collaborative Investment Series | Akros Monthly vs. Northern Lights |
| Goldman Sachs vs. Goldman Sachs ActiveBeta | Goldman Sachs vs. Goldman Sachs ActiveBeta | Goldman Sachs vs. Goldman Sachs ActiveBeta | Goldman Sachs vs. WisdomTree Europe Quality |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |